TopFunds

Humana

NYSE: HUM

Stock price

387.12 USD

(+0%) TODAY

Managed Health CareMedical - Healthcare Plans
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
8.4
4.1
16.8
12.2
20.1
25.3
22.7
22.1
20
10
9.8
1.6%
02Free cash flow per share
2.3
9.3
24.2
11.3
33.8
35.1
7.1
27.1
23.9
19.8
3.1
3.1%
03Dividends per share
1.2
0.9
1.9
2
2.2
2.5
2.8
3.2
3.5
3.5
3.5
11.9%
04Dividends payout, %
13.5%
28.8%
9%
15.8%
10.8%
9.6%
12.1%
14%
17.3%
35.7%
36.2%
10.4%
PROFIT AND LOSS STATEMENT
05Revenue
54,289
54,405
53,800
56,944
64,933
77,191
83,648
92,922
106,440
117,811
129,664
9.1%
06% Change
-
-
-
-
-
-
-
-
-
-
-
9.1%
07Cost of revenue
(44,177)
(44,896)
(43,389)
(45,753)
(53,740)
(61,501)
(69,199)
(75,690)
(88,394)
(100,664)
(110,812)
9.6%
08Gross profit
7,765
7,768
7,085
11,191
11,193
15,690
14,449
17,232
18,046
17,147
18,852
9.3%
09% Margin
14.3%
14.3%
13.2%
19.7%
17.2%
20.3%
17.3%
18.5%
17%
14.6%
14.5%
16.4% A
10Operating expenses
(7,765)
(7,768)
(7,085)
(9,117)
(7,723)
(11,016)
(11,030)
(13,668)
(14,726)
(15,520)
(17,399)
8.4%
11% of Revenue
(14.3)%
(14.3)%
(13.2)%
(16)%
(11.9)%
(14.3)%
(13.2)%
(14.7)%
(13.8)%
(13.2)%
(13.4)%
(13.8)% A
12Operating Income
2,347
1,741
3,326
2,074
3,470
4,674
3,419
3,564
3,320
1,627
1,453
(4.7)%
13Income tax expense
(1,155)
(938)
(1,572)
(391)
(763)
(1,307)
(485)
(762)
(836)
(413)
(250)
(14.2)%
14Net Income
1,276
614
2,448
1,683
2,707
3,367
2,933
2,806
2,489
1,207
1,188
(0.7)%
15% Margin
2.4%
1.1%
4.6%
3%
4.2%
4.4%
3.5%
3%
2.3%
1%
0.9%
2.8% A
16Shares Outstanding
151.1
150.9
145.6
138.4
134.7
133
129.4
127.1
124.4
120.9
120.8
(2.2)%
17EPS Basic
8.5
4.1
16.9
12.2
20.2
25.5
22.8
22.2
20.1
10
9.9
1.5%
18EPS Diluted
8.4
4.1
16.8
12.2
20.1
25.3
22.7
22.1
20
10
9.8
1.6%
19EBITDA
(270)
-
(936)
2,826
4,287
5,573
4,458
4,810
4,730
3,255
2,908
-
% Margin
(0.5)%
-
(1.7)%
5%
6.6%
7.2%
5.3%
5.2%
4.4%
2.8%
2.2%
3.3% A
20Net Interest Income (expense)
(186)
(189)
(242)
(218)
(242)
(283)
(326)
(401)
(493)
(660)
(631)
13%
21Net Debt / EBITDA
(5.6)
-
(0.9)
1.3
0.5
0.4
2.2
1.4
1.6
3.1
3
0.7 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
2,571
3,877
4,042
2,343
4,054
4,673
3,394
5,061
4,694
2,221
4,200
5%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
1,161
1,280
854
1,015
1,056
1,138
1,814
1,674
2,035
2,704
3,270
10.9%
25Other current assets
(319)
(461)
-
-
-
-
-
-
-
-
-
44.5%
26Inventory
-
-
-
-
-
-
-
-
-
-
-
-
27Total Current Assets
3,413
4,696
4,896
3,358
5,110
5,811
5,208
6,735
6,729
4,925
7,470
8.2%
Non-Current Assets
28Net property, plant & equipment
1,384
1,505
1,584
1,735
2,365
2,808
3,751
3,736
3,540
2,977
2,716
7%
29Long-term investments
9,110
9,798
12,302
11,484
12,441
14,936
14,113
15,010
17,748
19,332
16,834
6.3%
30Other non-current assets
11,216
9,813
7,902
8,767
9,127
11,522
21,676
18,244
18,875
19,078
21,730
6.8%
31Total Non-Current Assets
21,710
21,116
21,788
21,986
23,933
29,266
39,540
36,990
40,163
41,387
41,280
6.6%
Total Assets
25,123
25,812
26,684
25,344
29,043
35,077
44,748
43,725
46,892
46,312
48,750
6.9%
LIABILITIES
Current Liabilities
32Accounts payable
4,976
4,563
3,844
4,548
5,737
7,949
8,101
9,083
10,068
10,273
9,808
7%
33Short-term debt
299
600
150
1,694
815
729
2,138
2,263
1,612
724
150
(6.7)%
34Other current liabilities
364
280
378
283
247
318
254
286
266
260
356
(0.2)%
35Total Current Liabilities
5,639
5,443
4,372
6,525
6,799
8,996
10,493
11,632
11,946
11,257
10,314
6.2%
Non-Current Liabilities
36Long-term debt
3,794
3,492
4,770
4,375
5,299
6,415
11,087
9,490
10,657
11,536
12,787
12.9%
37Other non-current liabilities
5,344
6,192
7,700
4,283
4,908
5,938
7,065
7,233
7,971
7,074
7,912
4%
38Total Non-Current Liabilities
9,138
9,684
12,470
8,658
10,207
12,353
18,152
16,723
18,628
18,610
20,699
8.5%
39Total Liabilities
14,777
15,127
16,842
15,183
17,006
21,349
28,645
28,355
30,574
29,867
31,013
7.7%
SHAREHOLDERS` EQUITY
40Common stock
33
33
33
33
33
33
33
33
33
33
33
-
41Retained earnings / (deficit)
11,017
11,454
13,670
15,072
17,483
20,517
23,086
25,492
27,540
28,317
29,075
10.2%
42Accumulated other comprehensive income / (loss)
58
(66)
19
(159)
156
391
42
(1,304)
(999)
(1,067)
(633)
-
43Noncontrolling interests
-
-
-
-
-
-
23
59
56
70
80
36.6%
44Total shareholders' equity
10,346
10,685
9,842
10,161
12,037
13,728
16,103
15,370
16,318
16,445
17,737
5.5%
45Total Liabilities and shareholders' Equity
25,123
25,812
26,684
25,344
29,043
35,077
44,748
43,725
46,892
46,312
48,750
6.9%
46Total Debt
4,093
4,092
4,920
6,069
6,114
7,144
13,225
11,753
12,269
12,260
12,937
12.2%
47Net Debt
1,522
215
878
3,726
2,060
2,471
9,831
6,692
7,575
10,039
8,737
19.1%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
1,276
614
2,448
1,683
2,707
3,367
2,933
2,806
2,489
1,207
1,188
(0.7)%
49Depreciation & amortization
447
465
485
534
575
616
713
845
917
968
824
6.3%
50Share-based compensation expense
109
115
157
137
163
181
180
216
175
207
241
8.3%
51Changes in working capital and other assets
(964)
742
961
(181)
1,839
1,475
(1,564)
720
400
584
(1,332)
3.3%
52Net cash flows from operating activities
868
1,936
4,051
2,173
5,284
5,639
2,262
4,587
3,981
2,966
921
0.6%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(523)
(527)
(526)
(612)
(736)
(964)
(1,342)
(1,137)
(1,004)
(575)
(546)
0.4%
54Purchases of investments / marketable securities
(6,739)
(6,566)
(6,265)
(4,687)
(6,361)
(9,125)
(7,197)
(6,049)
(7,552)
(8,185)
(6,440)
(0.5)%
55Proceeds from maturities of marketable securities
6,558
5,738
3,879
4,466
5,819
7,733
6,144
3,799
5,087
6,358
9,422
3.7%
56Other investing activities
1,024
(7)
(29)
(2,254)
-
(709)
(4,161)
2,381
(23)
(550)
(163)
-
57Net cash flows from investing activities
320
(1,362)
(2,941)
(3,087)
(1,278)
(3,065)
(6,556)
(1,006)
(3,492)
(2,952)
2,273
21.7%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(385)
(104)
(3,365)
(1,090)
(1,070)
(1,820)
(79)
(2,096)
(1,573)
(817)
(151)
(8.9)%
59Dividends paid, net
(172)
(177)
(220)
(265)
(291)
(323)
(354)
(392)
(431)
(431)
(430)
9.6%
60Debt issuance (repayments), net
265
-
755
1,165
(423)
1,078
3,758
(1,394)
423
218
431
5%
61Other financing activities
(260)
1,013
1,885
(595)
(511)
(890)
(310)
1,968
725
(1,457)
(1,065)
15.1%
62Net cash flows from financing activities
(552)
732
(945)
(785)
(2,295)
(1,955)
3,015
(1,914)
(856)
(2,487)
(1,215)
8.2%
63Increase (decrease) in cash and cash equivalents
636
1,306
165
(1,699)
1,711
619
(1,279)
1,667
(367)
(2,473)
1,979
12%
64Cash and equivalents, ending balance
2,571
3,877
4,042
2,343
4,054
4,673
3,394
5,061
4,694
2,221
4,200
5%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
345
1,409
3,525
1,561
4,548
4,675
920
3,450
2,977
2,391
375
0.8%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Humana (HUM) financial statements and performance

Explore Humana (HUM) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.